ADHD treatments cost nearly £1m in Northamptonshire last year


More than 22,000 packets of drugs were prescribed to treat cases of Attention Deficit Hyperactivity Disorder (ADHD) in Northamptonshire last year at a cost of almost £1 million, new figures have revealed.

Figures obtained under the Freedom of Information Act showed that Northamptonshire Primary Care Trust (PCT) was one of the top 10 trusts for prescribing psychiatric drugs, such as Ritalin, Atomoxetine and Concerta.

Northamptonshire was seventh out of 152 PCTs for the cost of prescribing the psychiatric drugs with a total of £968,903.64.

The highest was Eastern and Coastal Kent with £1.7 million while the lowest was Knowsley, which spent just £83,624.71.

The data has been obtained by the Citizens Commission on Human Rights (CCHR) in a bid to highlight what they claim are the dangers of using drugs to treat the disorder.

Brian Daniels, a spokesperson for CCHR, said: “In real medicine, a patient can ask to see the results of a medical test or an exploratory examination.

“But in psychiatry, there are no tests and no results to confirm a so-called chemical imbalance of the brain. It is psychiatric crystal balling; it’s a case of make-it-up-as-you-go-along.

“There will be people who say the drugs work, but all the drugs are doing is producing nullifying effects that are hailed as ‘demonstrably effective.’

“All that has happened is the person has been drugged and is exhibiting the effects of a dangerous mind-altering foreign substance in his or her body. It’s brilliant marketing, but it’s not science.”

CCHR is urging people, especially parents, to seek the advice of non-psychiatric medical doctors, who can test for any undiagnosed physical conditions which may have been diagnosed as mental illness.

The Citizens Commission on Human Rights is an international psychiatric watchdog that was co-founded in 1969 by the Church of Scientology and Dr. Thomas Szasz, Professor of Psychiatry Emeritus, to investigate and expose psychiatric violations of human rights.

The Care Quality Commission recently reported a 50 per cent rise in the use of drugs for attention deficit hyperactivity disorder in England in six years.

The watchdog has warned health workers to “carefully monitor” their use as they have the potential to be “abused”. The number of prescriptions increased by 11 per cent between 2011 and 2012.